Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2021
Phase II consolidation trial with anti-Lewis-Y monoclonal antibody (hu3S193) in platinum-sensitive ovarian cancer after a second remissionOren Smaletz, Gustavo Ismael, Maria Del Pilar Estevez-Diz, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|February 16, 2017
First Brazilian Consensus of Advanced Prostate Cancer: Recommendations for Clinical PracticeAndre Deeke Sasse, Evanius Garcia Wiermann, Daniel Herchenhorn, et al.
Gynecologic Oncology|June 1, 2015
A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinomaOren Smaletz, Maria D P E Diz, Claudio C do Carmo, et al.
JCO Precision Oncology|November 15, 2021
Differential Activity of PARP Inhibitors in <i>BRCA1</i>- Versus <i>BRCA2</i>-Altered Metastatic Castration-Resistant Prostate CancerFadi Taza, Albert E Holler, Wei Fu, et al.
JAMA Network Open|January 13, 2025
Androgen Receptor Pathway Inhibitor Therapy for Advanced Prostate Cancer: Secondary Analysis of a Randomized Clinical TrialDiogo Assed Bastos, Andrey Soares, Fabio Augusto Barros Schutz, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2021
A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415)Fernando C Maluf, Fabio A Schutz, Eduardo H Cronemberger, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|May 1, 2019
Second brazilian consensus on the treatment of advanced prostate cancer - a SBOC-SBU-SBRT panel reviewAndré Deeke Sasse, Rodolfo Borges Dos Reis, Lucas Mendes Nogueira, et al.
Clinical Genitourinary Cancer|December 12, 2022
Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515)Diogo A Bastos, Aline Bobato Lara Gongora, Carlos Dzik, et al.
European Urology Oncology|December 10, 2023
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate CancerJacob J Orme, Fadi Taza, Navonil De Sarkar, et al.
Journal of Cancer Research and Clinical Oncology|April 9, 2024
Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus updateAndrey Soares, Fernando Sabino Marques Monteiro, Karine Martins da Trindade, et al.
Pageof 4